998 results on '"MacMillan, Margaret L."'
Search Results
2. Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host Disease
3. Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate–conditioned Fanconi anemia mice
4. FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia
5. Longitudinal clinical manifestations of Fanconi anemia: A systematized review
6. Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis
7. Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
8. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
9. Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
10. Treatment-Responsive Acute Graft-versus-Host Disease after Post-Transplantation Cyclophosphamide-Based Prophylaxis: Incidence and Clinical Outcomes
11. Treatment responsive acute GVHD after posttransplant cyclophosphamide-based prophylaxis: incidence and clinical outcomes
12. Predictors and outcomes of flares in chronic graft-versus-host disease
13. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
14. Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
15. Prediction of outcomes after second-line treatment for acute graft-versus-host disease
16. A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice
17. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
18. Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review.
19. Development of specific growth charts for children with Fanconi anemia.
20. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
21. Hepatomegaly and Ascites Are Common in Immediate Post Hematopoietic Stem Cell Transplant Period in Pediatric and Adult Patients Not Diagnosed with Sinusoidal Obstruction Syndrome
22. Treatment Responsive Acute Gvhd Following Posttransplant Cyclophosphamide Based Prophylaxis: Incidence and Clinical Outcomes
23. A High Proportion of Abnormal Pulmonary Baseline Investigations in Pediatric BMT Patients: Prospective, Multi-Center Results from the Transpire Study.
24. Transpire: Lung Injury in a Longitudinal Cohort of Pediatric Hematopoietic Stem Cell Transplant Patients
25. Success and Feasibility of Multiple Breath Washout: Prospective, Multi-Center Results from the Transpire Study
26. Measurement of Respiratory System Function By Airwave Oscillometry (AOS) in a Cohort of Children Undergoing Hematopoietic Stem Cell Transplant (HSCT)
27. Breathing New Life into an Old Problem: Pulmonary Complications after Autologous Hematopoietic Stem Cell Transplant
28. Graft Vs Host Disease (GVHD) in Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients and Impact on Overall Survival: A CIBMTR Analysis
29. Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion
30. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
31. Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation
32. Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study
33. First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
34. Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes
35. Low 5-year health care burden after umbilical cord blood transplantation
36. Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report
37. Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant
38. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency
39. Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
40. Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease
41. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
42. Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome
43. Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation
44. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation
45. Mediport use as an acceptable standard for CAR T cell infusion
46. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
47. Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report
48. Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
49. Pediatric acute GVHD: clinical phenotype and response to upfront steroids
50. Bone Mineral Density in Children with Fanconi Anemia after Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.